Suppr超能文献

轻症 COVID-19 患者肺功能恢复的临床预测因子。

Clinical predictors of lung function in patients recovering from mild COVID-19.

机构信息

Clínica de Enfermedades Respiratorias, Hospital Regional de Alta Especialidad de La Peninsula de Yucatan, Calle 7 #433 por 20 y 22. Fracc. Altabrisa, Mérida, Yucatan, Mexico.

Department of Physiology and Membrane Biology, University of California, Davis, USA.

出版信息

BMC Pulm Med. 2022 Jul 31;22(1):294. doi: 10.1186/s12890-022-02086-9.

Abstract

BACKGROUND

Few studies have assessed lung function in Hispanic subjects recovering from mild COVID-19. Therefore, we examined the prevalence of impaired pulmonary diffusing capacity for carbon monoxide (DLCO) as defined by values below the lower limit of normal (< LLN, < 5th percentile) or less than 80% of predicted in Hispanics recovering from mild COVID-19. We also examined the prevalence of a restrictive spirometric pattern as defined by the ratio of forced expiratory volume in 1 s (FEV) to forced vital capacity (FVC) being ≥ LLN with the FVC being < LLN. Finally, we evaluated previous studies to find factors correlated to impaired DLCO post-COVID-19.

METHODS

In this observational study, adult patients (n = 146) with mild COVID-19 were recruited from a long-term follow-up COVID-19 clinic in Yucatan, Mexico, between March and August 2021. Spirometry, DLCO, and self-reported signs/symptoms were recorded 34 ± 4 days after diagnosis.

RESULTS

At post-evaluation, 20% and 30% of patients recovering from COVID-19 were classified as having a restrictive spirometric pattern and impaired DLCO, respectively; 13% had both. The most prevalent reported symptoms were fatigue (73%), a persistent cough (43%), shortness of breath (42%) and a blocked/runny nose (36%). Increased age and a restrictive spirometric pattern increased the probability of having an impaired DLCO while having a blocked nose and excessive sweating decreased the likelihood. The proportion of patients with previous mild COVID-19 and impaired DLCO increased by 13% when the definition of impaired DLCO was < 80% predicted instead of below the LLN. When comparing previous studies, having severe COVID-19 increased the proportion of those with impaired DLCO by 21% compared to those with mild COVID-19.

CONCLUSIONS

One-third of patients with mild COVID-19 have impaired DLCO thirty-four days post-diagnosis. The criteria that define impaired DLCO and the severity of COVID-19 disease affects the proportion of those with impaired DLCO at follow-up. One-fifth of patients have a restrictive spirometric pattern.

摘要

背景

很少有研究评估从轻度 COVID-19 中康复的西班牙裔患者的肺功能。因此,我们检查了在从轻度 COVID-19 中康复的西班牙裔患者中,定义为低于正常值下限(<LLN,<第 5 百分位)或低于预测值 80%的肺一氧化碳弥散量(DLCO)受损的患病率。我们还检查了以第 1 秒用力呼气量(FEV)与用力肺活量(FVC)的比值大于等于 LLN 而 FVC 小于 LLN 的限制性肺量计模式的患病率,定义为受限模式。最后,我们评估了以前的研究,以找到与 COVID-19 后 DLCO 受损相关的因素。

方法

在这项观察性研究中,从 2021 年 3 月至 8 月在墨西哥尤卡坦州的一个长期 COVID-19 诊所招募了 146 名患有轻度 COVID-19 的成年患者。在诊断后 34 ± 4 天记录肺量计、DLCO 和自我报告的体征/症状。

结果

在评估后,20%和 30%的 COVID-19 康复患者分别被归类为存在限制性肺量计模式和 DLCO 受损,13%的患者同时存在两种情况。最常见的报告症状是疲劳(73%)、持续咳嗽(43%)、呼吸急促(42%)和鼻塞/流鼻涕(36%)。年龄增加和限制性肺量计模式增加了 DLCO 受损的可能性,而鼻塞和过度出汗则降低了可能性。当使用低于预测值 80%的 DLCO 而不是低于 LLN 来定义 DLCO 受损时,以前患有轻度 COVID-19 和 DLCO 受损的患者比例增加了 13%。当比较以前的研究时,与患有轻度 COVID-19 的患者相比,患有严重 COVID-19 的患者 DLCO 受损的比例增加了 21%。

结论

三分之一的轻度 COVID-19 患者在诊断后 34 天 DLCO 受损。定义 DLCO 受损的标准和 COVID-19 疾病的严重程度会影响随访时 DLCO 受损患者的比例。五分之一的患者存在限制性肺量计模式。

相似文献

1
Clinical predictors of lung function in patients recovering from mild COVID-19.
BMC Pulm Med. 2022 Jul 31;22(1):294. doi: 10.1186/s12890-022-02086-9.
3
Influence of reduced diffusing capacity and FEV on outcome after cardiac surgery.
Acta Anaesthesiol Scand. 2021 Oct;65(9):1221-1228. doi: 10.1111/aas.13935. Epub 2021 Jun 23.
4
Resting Physiological Correlates of Reduced Exercise Capacity in Smokers with Mild Airway Obstruction.
COPD. 2017 Jun;14(3):267-275. doi: 10.1080/15412555.2017.1281901. Epub 2017 Apr 3.
5
Restrictive spirometry versus restrictive lung function using the GLI reference values.
Clin Physiol Funct Imaging. 2022 May;42(3):181-189. doi: 10.1111/cpf.12745. Epub 2022 Feb 28.
6
Fixed ratio or lower limit of normal for the FEV /VC ratio: relation to symptoms and extended lung function tests.
Clin Physiol Funct Imaging. 2017 May;37(3):263-269. doi: 10.1111/cpf.12294. Epub 2015 Oct 6.
7
Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase.
Respir Res. 2020 Jun 29;21(1):163. doi: 10.1186/s12931-020-01429-6.

引用本文的文献

2
Recovery of lung function during the first year after COVID-19: a systematic review and meta-analysis.
Eur Respir Rev. 2025 Aug 20;34(177). doi: 10.1183/16000617.0029-2025. Print 2025 Jul.
3
A comparison of pulmonary function pre and post mild SARS-CoV-2 infection among healthy adults.
BMC Pulm Med. 2025 Apr 8;25(1):163. doi: 10.1186/s12890-025-03613-0.
4
Mexican Hispanics show significant improvement in lung function approximately 1 year after having severe COVID-19.
Exp Physiol. 2024 Dec;109(12):2147-2157. doi: 10.1113/EP091934. Epub 2024 Oct 24.

本文引用的文献

1
Risk factors for impaired pulmonary diffusion function in convalescent COVID-19 patients: A systematic review and meta-analysis.
EClinicalMedicine. 2022 Jul;49:101473. doi: 10.1016/j.eclinm.2022.101473. Epub 2022 May 27.
2
Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people.
PLoS Med. 2021 Sep 28;18(9):e1003777. doi: 10.1371/journal.pmed.1003777. eCollection 2021 Sep.
3
Factors Associated With Severe COVID-19 Infection Among Persons of Different Ages Living in a Defined Midwestern US Population.
Mayo Clin Proc. 2021 Oct;96(10):2528-2539. doi: 10.1016/j.mayocp.2021.06.023. Epub 2021 Jul 5.
5
Gas Exchange Impairment During COVID-19 Recovery.
Respir Care. 2021 Oct;66(10):1610-1617. doi: 10.4187/respcare.09114. Epub 2021 Aug 31.
6
More than 50 long-term effects of COVID-19: a systematic review and meta-analysis.
Sci Rep. 2021 Aug 9;11(1):16144. doi: 10.1038/s41598-021-95565-8.
8
Impaired diffusing capacity for carbon monoxide is common in critically ill Covid-19 patients at four months post-discharge.
Respir Med. 2021 Jun;182:106394. doi: 10.1016/j.rmed.2021.106394. Epub 2021 Apr 15.
9
Symptoms, Pulmonary Function, and Functional Capacity Four Months after COVID-19.
Ann Am Thorac Soc. 2021 Nov;18(11):1912-1917. doi: 10.1513/AnnalsATS.202012-1489RL.
10
Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19.
JAMA. 2021 Apr 20;325(15):1525-1534. doi: 10.1001/jama.2021.3331.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验